A Study on Kattrazhai Ennai in the Management of Kodhippu Kanam in Children

Preclinical and Clinical Evaluation of the Effect On Oral Administration of KATTRAZHAI ENNAI in the Management of KODHIPPU KANAM(ACUTE PHARYNGITIS) in Children - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061545

Enrollment

Registered

2024-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified

Interventions

Intervention1: KATTRAZHAI ENNAI(Internal Administration): Should be administrated orally twice a day after food in take. Dosage(according age of the patient) 2 to 10ML. Duration-14 days. Control Int

Eligibility

Inclusion criteria

Inclusion criteria: Cough Fever Sore throat Loss of appetite Head ache Muffled voice Difficulty in swallowing

Exclusion criteria

Exclusion criteria: Children above 12 years Children below 3 years History of active primary complex Tonsillitis Epiglottis Severe asthma Long term fever Any other serious illness

Design outcomes

Primary

Measure	Time frame
This Study Will help to Understand the Effects of KATTRAZHAI ENNAI in the Management of KODHIPPU KANAM(ACUTE PHARYNGITIS) in ChildrenTimepoint: 2 years	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K Shyamala MD s

Government Siddha Medical College And Hospital

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026